Logo Image
News
Global BulletinAll NewsFDA Approval AlertWomen in Oncology
Media
Around the PracticeBetween the LinesFace OffFrom All AnglesMeeting of the MindsOncViewPodcastsShortsTraining AcademyTreatment Algorithms with the Oncology BrothersVideos
Conferences
Publications
All JournalsEditorial BoardFor AuthorsYear in Review
More
Events
Frontline ForumSatellite Sessions
CME/CE
Resources
Awareness MonthThe Bispecifics NetworkNurse Practitioners/Physician's AssistantsPartnersSponsoredSponsored Media
Career Center

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • Events
  • CME/CE
  • Resources
  • Career Center
  • Subscribe
  • Adverse Effects
  • Artificial Intelligence
  • Brain Cancer
  • Breast Cancer
    • HER2-Positive Breast Cancer
    • Triple-Negative Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Esophageal Cancer
    • Pancreatic Cancer
    • Gastric Cancer
    • Liver Cancer
  • Genitourinary Cancers
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Ovarian Cancer
    • Cervical Cancer
  • Head & Neck Cancer
  • Hematologic Oncology
    • Multiple Myeloma
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasms
  • Infection
    • Vaccines
  • Leukemia
  • Lung Cancer
    • Small Cell Lung Cancer (SCLC)
    • Non-Small Cell Lung Cancer (NSCLC)
  • Lymphoma
  • Neuroendocrine Tumors
  • Oncology
  • Pediatric Cancers
  • Psycho-Oncology
  • Radiation Oncology
  • Sarcoma
  • Screening
  • Skin Cancer & Melanoma
  • Surgery
  • Thyroid Cancer
Spotlight -
Psycho-Oncology|
Artificial Intelligence|
Career Center|
Radiation Oncology|
Surgery
Advertisement

Stephanie A. Berg, DO

Advertisement

Articles by Stephanie A. Berg, DO

Traversing the Complexities of Non-Clear Cell Renal Cell Carcinoma

ByManojkumar Bupathi, MD, MS,Benjamin Garmezy, MD,Stephanie A. Berg, DO
March 7th 2025

A brief overview of the current RCC landscape was provided in the most recent Oncology Decoded podcast.

2 experts are featured in this series.

Episode 3: Traversing the Complexities of Non-Clear Cell Renal Cell Carcinoma

ByManojkumar Bupathi, MD, MS,Ben Garmezy, MD,Stephanie A. Berg, DO
March 7th 2025

A brief overview of the current RCC landscape was provided in the most recent Oncology Decoded podcast.

Advertisement

Latest Updated Articles

  • 2 experts are featured in this series.
    Episode 3: Traversing the Complexities of Non-Clear Cell Renal Cell Carcinoma

    March 7th 2025

  • Traversing the Complexities of Non-Clear Cell Renal Cell Carcinoma
    Traversing the Complexities of Non-Clear Cell Renal Cell Carcinoma

    March 7th 2025



Advertisement
Advertisement

Trending on CancerNetwork

1

FDA Approves RP1/Nivolumab for Progression on Anti–PD-1 Therapy in Melanoma

2

The Lowest-Ever Hazard Ratio in Multiple Myeloma Bispecific Trials?

3

Developers Initiate Phase 2/3 Ivonescimab/EV Trial in Bladder Cancer

4

Why Earlier CAR T-Cell Therapy May Benefit Patients With Multiple Myeloma

5

GLP-1 Receptor Agonists and Cancer: Renewed Momentum for Metabo-Oncology

  • About
  • Advertise
  • CureToday.com
  • OncLive.com
  • OncNursingNews.com
  • TargetedOnc.com
  • Editorial
  • Contact
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us